COMMUNIQUÉS West-GlobeNewswire

Ally Medical ER Is Coming to Magnolia
09/06/2026
A new 24/7 emergency room is coming to Montgomery County's fastest-growing community, designed with local families in mind MAGNOLIA, Texas, June 09, 2026 (GLOBE NEWSWIRE) -- Ally Medical Emergency Room has announced [...]
FDA Expands Sunscreen Options for the First Time in 20 Years
09/06/2026
Silver Spring, Md., June 09, 2026 (GLOBE NEWSWIRE) -- Today, the U.S. Food and Drug Administration added bemotrizinol to the list of permitted sunscreen active ingredients, marking a significant milestone in the agency' [...]
Flyte Announces World Cup Activation Strategy, Targeting Global Travel Demand Surrounding 2026 Tournament
09/06/2026
Company Positions Platform to Capture High-Value Regional Travel Demand and Build Brand Exposure during Largest Global Sporting Event Northeast Corridor Routes Aligned with Key U.S. Host Markets to Drive Customer [...]
Shattuck Labs Announces Exercise of Outstanding Common Stock Warrants and Provides Financial Update
09/06/2026
AUSTIN, Texas and DURHAM, N.C., June 09, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of potentially first-in-class monoclonal [...]
Le gala Le Bal Rouge de la Fondation du CUSM recueille un montant record de 2 223 306 $ pour accélérer les découvertes en santé au site Glen du CUSM
09/06/2026
MONTRÉAL, 09 juin 2026 (GLOBE NEWSWIRE) -- Le gala phare de la Fondation du CUSM, Le Bal Rouge, a réuni les leaders les plus engagés des milieux montréalais des affaires, de la philanthropie et de la santé pour célébrer [...]
The MUHC Foundation’s Le Bal Rouge Gala raises $2,223,306 million to accelerate discovery in health care at the MUHC’s Glen site
09/06/2026
MONTREAL, June 09, 2026 (GLOBE NEWSWIRE) -- The MUHC Foundation’s signature gala, Le Bal Rouge , brought together Montreal’s most passionate leaders in business, philanthropy and health care to celebrate innovation at [...]
Chiesi Global Rare Diseases Announces Health Canada Grants Priority Review for FILSUVEZ® (birch triterpenes) Topical Gel for the Treatment of Epidermolysis Bullosa
09/06/2026
Priority review recognizes the serious nature of epidermolysis bullosa (EB) and the urgent need for continued evaluation of potential treatment options If approved, FILSUVEZ has the potential to become the first therapy [...]
Matisse Pharmaceuticals receives FDA Fast Track Designation for isupartob sodium in sepsis
09/06/2026
Geleen, June 9, 2026 Matisse Pharmaceuticals B.V., a clinical stage company developing a medicinal product for the treatment of sepsis, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast [...]
R1 Appoints Eric Tagliere as Chief Information Officer
09/06/2026
CHICAGO, June 09, 2026 (GLOBE NEWSWIRE) -- R1 (“R1” or the “Company”), the leader in healthcare revenue management, today announced that Eric Tagliere has joined the Company as Chief Information Officer. In this role, [...]
Windward Bio Doses First Patients in Phase 2 SIRIUS COPD Study of Ultra Long-Acting Anti-TSLP Antibody WIN378
09/06/2026
COPD study initiation expands WIN378 development into a second major respiratory disease WIN378 is currently being evaluated in the Phase 2/3 POLARIS asthma study, with initial Phase 2 data expected in the second half [...]
Linnaeus Therapeutics Announces Selection of LNS8801 into the National Institute on Aging Interventions Testing Program
09/06/2026
Selection by both the NIA ITP and ARPA-H PROSPR programs highlights growing recognition of LNS8801’s potential to promote healthy aging HADDONFIELD, N.J., June 09, 2026 (GLOBE NEWSWIRE) -- Linnaeus Therapeutics, Inc., a [...]
SCIENTURE Secures Formulary Coverage for REZENOPY™ with a Large National Health Plan and Expands Commercial Team
09/06/2026
Commercial Launch Planned for Mid-July; 5,000+ Healthcare Facilities Reached Through GPO Agreements, Covering ~60% of Institutional GPO Market U.S. naloxone market totals ~$144 million in annual sales and ~9.8 million [...]
Imviva Biotech Receives FDA Investigational New Drug Approval for CTA313, a Dual-Targeted CD19/BCMA Allogeneic CAR-T Cell Therapy for Autoimmune Diseases
09/06/2026
Approval paves the way for CTA313 clinical study in the United States for patients with systemic lupus erythematosus, progressive multiple sclerosis, and autoimmune encephalitis BOSTON, June 09, 2026 (GLOBE NEWSWIRE [...]
BPC-157 Research Peptide: Koi Peptides Launches a COA-Verified Reference Compound for Laboratory Use
09/06/2026
Cheyenne, Wyoming, June 09, 2026 (GLOBE NEWSWIRE) -- Koi Peptides has launched BPC-157, a synthetic pentadecapeptide, as a research-use-only reference compound for laboratory use. Each batch is characterized by HPLC for [...]
Palisade Bio to Present on the Potential of PALI-2108 for Fibrostenotic Crohn’s Disease at New York Academy of Sciences Symposium
09/06/2026
Presentation to highlight fibrostenotic Crohn’s disease biology and the potential of a locally bioactivated PDE4 inhibitor prodrug approach Denver, CO, June 09, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI [...]
International Myeloma Foundation (IMF) and International Myeloma Working Group (IMWG) to Honor 2026 Kyle and Durie Achievement Awardees, Dr. Hermann Einsele and Dr. Noopur Raje
09/06/2026
Awarding ceremonies to be held today, June 9, 2026, at the 17th Annual IMWG Summit in Stockholm, Sweden STOCKHOLM, June 09, 2026 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) and the International [...]
Ernexa Therapeutics Highlights Ovarian Cancer Unmet Need, Hope for Patients and Potential Accessibility Advantages of ERNA-101 in Virtual Investor KOL Connect Segment Featuring Dr. Ira Winer
09/06/2026
Discussion explores challenges of immunologically “cold” tumors and the potential for scalable engineered cell therapies to expand patient access in oncology Access the segment here CAMBRIDGE, Mass., June 09, 2026 ( [...]
Disc Medicine Provides Update from FDA Type A Meeting for Bitopertin in Erythropoietic Protoporphyria
09/06/2026
Aligned with the FDA that the Phase 3 APOLLO study, if successful, can serve as the basis for CRL response and could potentially support a traditional approval On track for expected CRL response submission by end of [...]
ENvue Medical Launches AI Training Platform Establishing Artificial Intelligence Foundation for Robotic Feeding Tube Navigation
09/06/2026
AI-based platform, ‘Ask Oscar™’, to accelerate adoption of ENvue's Navigation Platform and enable clinicians to train independently and reduce implementation barriers See Ask Oscar in action: https://envuemed.com/ask- [...]

Pages